APOPW — Stock Film
STOCK FILMSCENE 1/10APOPW · $0.09
Stock Expert AI presents
APOPW
Cellect Biotechnology Ltd. Warrants to Purchase ADR (1 WT and $7.50 to purchase 1 ADS)
~4 min film100% real numbers0 jargon
WHAT DOES THIS COMPANY DO?
Cellect Biotechnology Ltd. Warrants to Purchase ADR (1 WT and $7.50 to purchase 1 ADS). A quick introduction.

On the stock market since 2016, it operates in its own corner of the market. Now — the numbers.

on the stock market since 2016
$0 market value
Revenue last year:
$0
The loss that same year:
$0
Sales don’t cover the costs; the gap drains from the cash pile every year.

The company is still in the product-building phase: its spending runs far above its sales. That only changes once the product starts selling at scale.

THE SALES TREND
The sales picture, year by year.

Red columns mark years that ended in a loss.

$0
2021
$0
2022
$0
2023
$0
2024
$0
2025
In the vault right now:
$0
DEBT: $0
At this pace, that money lasts about 241.6 years.

Before the clock runs out, either sales must climb sharply or new money must come in. For now, time is on the company’s side.

What executives did with their own stock over the last 12 months:
26 buy0 sell

Executives buying with their own money is usually read as confidence in the company’s future.

THE FIVE-YEAR JOURNEY
A big climb, then a hard fall.

An investor who bought at the very peak is down 82% today. The business is the same; what changed most is the price — and the expectations — the market pins on it.

1
THE BRIGHT SIDE · 1/2
Strong cash, light debt

There is $3.8B in the vault; even if every debt were paid off, $3.8B would remain.

2
THE BRIGHT SIDE · 2/2
Executives are buying their own stock

Over the last 12 months, company executives reported 26 buys and 0 sells. Management buying with its own money is usually read as a good sign.

1
THE RISKS · 1/3
Small sales, big loss

A loss of $15.8M against $0 in annual sales.

2
THE RISKS · 2/3
Trading under $1

The stock sits at $0.09. Under exchange rules, stocks that stay below $1 for too long risk being removed from the market.

3
THE RISKS · 3/3
A wildly swinging price

This stock swings about 2.3 times as much as the market average. Big rallies — and big drops — can both happen fast.

FINALE · THE GRADE
D
0 / 100 · MoonshotScore

On our five-subject report card, APOPW sits behind the class. A low grade doesn’t mean “doomed” — it means “big claim, small proof.”

The takeaway: APOPW is a high-risk stock — not yet profitable, and its future rides on its product catching on.

What would you like to do next?
Open the stock page →
This was a film — not investment advice.
Data: FMP & company filings
Aug 21, 2026 · stockexpertai.com · Stock Film